RATIONALE: Studies in humans and rodents have indicated a causative role for CD8(+) T cells in IgE-mediated allergic inflammation, but their function is still controversial. OBJECTIVES: To analyze the role of allergen-specific CD8(+) T cells during the development of allergic airway inflammation in two parallel but diverging outcome models. METHODS: We used H2-Kb SIINFEKL (OVA(257-264)) multimers to analyze induction, natural distribution, and phenotype of allergen-specific CD8(+) T cells in a murine C57BL/6 model of ovalbumin (OVA)-induced allergic airway inflammation using low-dose or high-dose OVA sensitization. MEASUREMENTS AND MAIN RESULTS: The low-dose protocol was characterized by a significant induction of total and OVA-specific IgE, eosinophilic airway inflammation, IL-4 levels in bronchoalveolar lavage fluid. And significant alterations in lung function. The high dose protocol was characterized by a significant reduction of the allergic phenotype. Using OVA(257-264) H2-Kb multimers, we observed lung and airway infiltrating OVA-specific CD8(+) T cells showing an effector/effector-memory phenotype. The high-dose protocol caused significantly higher infiltration of allergen-specific CD8(+) cells to the airways and enhanced their cytotoxicity. Adoptive transfer with CD8(+) T cells from transgenic OT-I mice to TAP1(-/-) or wild-type mice showed their migration to the lungs and TAP1-dependent proliferation after OVA-aerosol exposure. TAP1(-/-) mice defective in CD8(+) T cells showed exacerbated symptoms in the low-dose sensitization model. CONCLUSIONS: Allergen-specific CD8(+) T cells seem to protect from allergic inflammation in the lungs. Their number, which is dependent on the sensitization dose, appears to be a critical predictor for the severity of the allergic phenotype.
RATIONALE: Studies in humans and rodents have indicated a causative role for CD8(+) T cells in IgE-mediated allergic inflammation, but their function is still controversial. OBJECTIVES: To analyze the role of allergen-specific CD8(+) T cells during the development of allergic airway inflammation in two parallel but diverging outcome models. METHODS: We used H2-Kb SIINFEKL (OVA(257-264)) multimers to analyze induction, natural distribution, and phenotype of allergen-specific CD8(+) T cells in a murine C57BL/6 model of ovalbumin (OVA)-induced allergic airway inflammation using low-dose or high-dose OVA sensitization. MEASUREMENTS AND MAIN RESULTS: The low-dose protocol was characterized by a significant induction of total and OVA-specific IgE, eosinophilic airway inflammation, IL-4 levels in bronchoalveolar lavage fluid. And significant alterations in lung function. The high dose protocol was characterized by a significant reduction of the allergic phenotype. Using OVA(257-264) H2-Kb multimers, we observed lung and airway infiltrating OVA-specific CD8(+) T cells showing an effector/effector-memory phenotype. The high-dose protocol caused significantly higher infiltration of allergen-specific CD8(+) cells to the airways and enhanced their cytotoxicity. Adoptive transfer with CD8(+) T cells from transgenic OT-I mice to TAP1(-/-) or wild-type mice showed their migration to the lungs and TAP1-dependent proliferation after OVA-aerosol exposure. TAP1(-/-) mice defective in CD8(+) T cells showed exacerbated symptoms in the low-dose sensitization model. CONCLUSIONS: Allergen-specific CD8(+) T cells seem to protect from allergic inflammation in the lungs. Their number, which is dependent on the sensitization dose, appears to be a critical predictor for the severity of the allergic phenotype.
Authors: Jeffrey T McNamara; Craig M Schramm; Anurag Singh; Eric R Secor; Linda A Guernsey; Leo Lefrançois; Roger S Thrall Journal: Am J Pathol Date: 2012-03-24 Impact factor: 4.307
Authors: Regan J Anderson; Ching-wen Tang; Naomi J Daniels; Benjamin J Compton; Colin M Hayman; Karen A Johnston; Deborah A Knight; Olivier Gasser; Hazel C Poyntz; Peter M Ferguson; David S Larsen; Franca Ronchese; Gavin F Painter; Ian F Hermans Journal: Nat Chem Biol Date: 2014-10-05 Impact factor: 15.040
Authors: Antonio Aguilar-Pimentel; Anke Graessel; Francesca Alessandrini; Helmut Fuchs; Valerie Gailus-Durner; Martin Hrabě de Angelis; Dennis Russkamp; Adam Chaker; Markus Ollert; Simon Blank; Jan Gutermuth; Carsten B Schmidt-Weber Journal: PLoS One Date: 2017-06-01 Impact factor: 3.240
Authors: Xiaoli Meng; Zaid Al-Attar; Fiazia S Yaseen; Rosalind Jenkins; Caroline Earnshaw; Paul Whitaker; Daniel Peckham; Neil S French; Dean J Naisbitt; B Kevin Park Journal: J Immunol Date: 2017-04-24 Impact factor: 5.422
Authors: Marion Horsch; Juan Antonio Aguilar-Pimentel; Clemens Bönisch; Christophe Côme; Cathrine Kolster-Fog; Klaus T Jensen; Anders H Lund; Icksoo Lee; Lawrence I Grossman; Christopher Sinkler; Maik Hüttemann; Erwin Bohn; Helmut Fuchs; Markus Ollert; Valérie Gailus-Durner; Martin Hrabĕ de Angelis; Johannes Beckers Journal: PLoS One Date: 2015-08-11 Impact factor: 3.240